期刊
CLINICAL NEUROLOGY AND NEUROSURGERY
卷 106, 期 1, 页码 5-8出版社
ELSEVIER SCIENCE BV
DOI: 10.1016/S0303-8467(03)00046-5
关键词
myasthenia gravis; tacrolimus hydrate; immunosuppressant; sensitivity test
Tacrolimus hydrate (FK506) reduces myasthenic symptoms due to its immunosuppressive properties. We studied the therapeutic effects of FK506 and noted improvement in 7 of 13 myasthenic patients on the clinical muscle test (myasthenia gravis, MG score). Two other patients with relapsing ocular symptoms improved. We also examined patient sensitivity to FK506, but could not predict such sensitivity before FK506 treatment in the present study. (C) 2003 Elsevier B.V. All fights reserved.
作者
我是这篇论文的作者
点击您的名字以认领此论文并将其添加到您的个人资料中。
推荐
暂无数据